A Phase 1 Clinical Trial to evaluate the effect of the study drug in people with moderate to severe Crohn's Disease.
|Study number||5605 - RECRUITMENT CURRENTLY ON HOLD|
|Group||People with moderate to severe Crohn's Disease|
|Gender||Male / Female|
|Age||18 - 65|
|Compensation||Up to a maximum of £4,552|
|Recruiting from||Oct 2018|
|Additional details||Study commitment last 30 weeks and consists of three 2-night residential stays on the CRU, in addition to a screening visit and 4 outpatient visits on the CRU. BMI between 18 – 35 kg/m2 (inclusive) with a body weight between 45 – 110kg.|